P. Beaumier

发表

Use of I-131 labeled, murine Fab against a high molecular weight antigen of human melanoma: preliminary experience.

S. Larson, J. Carrasquillo, K. Krohn, 1985, Radiology.

Preliminary studies of monoclonal antibody lymphoscintigraphy in malignant melanoma.

J. Eary, W. Nelp, K. Krohn, 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Characterization of a high-affinity monoclonal antibody specific for CD44v6 as candidate for immunotherapy of squamous cell carcinomas

K. Heider, H. Ahorn, G. Adolf, 1996, Cancer Immunology, Immunotherapy.

Clinical optimization of pretargeted radioimmunotherapy with antibody-streptavidin conjugate and 90Y-DOTA-biotin.

P. Beaumier, P. Weiden, H. Breitz, 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Erythropoiesis Equivalence, Pharmacokinetics and Immune Response following Repeat Hematide™ Administration in Cynomolgus Monkeys

P. Schatz, K. Woodburn, P. Beaumier, 2010, International journal of immunopathology and pharmacology.

I86Re Radioimmunotherapy of Small Cell Lung Carcinoma in Nude Mice

L. L. Kunz, P. Beaumier, P. Abrams, 2006 .

Localization of 131I-labeled p97-specific Fab fragments in human melanoma as a basis for radiotherapy.

S. Larson, M. Graham, J. Brown, 1983, The Journal of clinical investigation.

Approaches to improved antibody- and peptide-mediated targeting for imaging and therapy of cancer

P. Beaumier, J. Reno, A. Fritzberg, 1994 .

Pilot trial of murine monoclonal antibodies in patients with advanced melanoma.

G. Goodman, I. Hellstrom, K. Hellström, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High-level iodination of monoclonal antibody fragments for radiotherapy.

S. Larson, J. Brown, J. Carrasquillo, 1984, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Development and biologic evaluation of a kit for preformed chelate technetium-99m radiolabeling of an antibody Fab fragment using a diamide dimercaptide chelating agent.

J. Fitzner, P. Beaumier, T. Rao, 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Optimal antibody-radionuclide combinations for clinical radioimmunotherapy: a predictive model based on mouse pharmacokinetics.

E. Yorke, B. Wessels, P. Beaumier, 1991, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Diagnosis of and therapy for solid tumors with radiolabeled antibodies and immune fragments.

S. Larson, J. Brown, J. Carrasquillo, 1984, Cancer treatment reports.

High-Levellodinationof MonoclonalAntibodyFragmentsfor Radiotherapy

K. Krohn, J. Ferens, P. Beaumier, 2006 .

Evaluation of L6, an anti-carcinoma murine monoclonal antibody, in tumor-bearing nude mice.

E. Lavie, K. Hellström, I. Hellström, 1989, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Immunoreactivity assay for labeled anti-melanoma monoclonal antibodies.

J. Eary, W. Nelp, K. Krohn, 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Autoradiolysis of iodinated monoclonal antibody preparations.

J. Eary, W. Nelp, K. Krohn, 1986, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Melanoma localization in nude mice with monoclonal Fab against p97.

S. Larson, J. Eary, W. Nelp, 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Delivery of melanoma-associated immunoglobulin monoclonal antibody and Fab fragments to normal brain utilizing osmotic blood-brain barrier disruption.

E. Neuwelt, K. Hellstrom, K. Hellström, 1988, Cancer research.

Effects of liposome size on the degradation of bovine brain sphingomyelin/cholesterol liposomes in the mouse liver.

P. Beaumier, K. Hwang, 1983, Biochimica et biophysica acta.

Targeted proteins for diagnostic imaging: does chemistry make a difference?

P. Beaumier, A. Fritzberg, 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Specific and stable labeling of antibodies with technetium-99m with a diamide dithiolate chelating agent.

D. Wilbur, P. Beaumier, T. Rao, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Dosimetry of rhenium-186-labeled monoclonal antibodies: methods, prediction from technetium-99m-labeled antibodies and results of phase I trials.

P. Beaumier, D. Fisher, P. Weiden, 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Hepatic uptake and degradation of unilamellar sphingomyelin/cholesterol liposomes: a kinetic study.

P. Beaumier, K. Hwang, K. F. Luk, 1980, Proceedings of the National Academy of Sciences of the United States of America.

Pretargeted radioimmunotherapy in tumored mice using an in vivo 212Pb/212Bi generator.

P. Beaumier, D. Axworthy, F. Su, 2005, Nuclear medicine and biology.

Uptake of small liposomes by non-reticuloendothelial tissues.

P. Beaumier, J. Lai, M. Padki, 1987, Biochimica et biophysica acta.

Immunotoxins of Pseudomonas exotoxin A (PE): effect of linkage on conjugate yield, potency, selectivity and toxicity.

G. Sivam, P. Beaumier, P. Abrams, 1990, Molecular immunology.

Encapsulation, with high efficiency, of radioactive metal ions in liposomes.

P. Beaumier, K. Hwang, K. F. Luk, 1982, Biochimica et biophysica acta.

Rhenium-186-labeled chimeric antibody NR-LU-13: pharmacokinetics, biodistribution and immunogenicity relative to murine analog NR-LU-10.

P. Beaumier, P. Weiden, M. Bjorn, 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

An EfficientMethodfor LoadingIndium-111 into LiposomesUsing Acetylacetone

P. Beaumier, K. Hwang, 2006 .

Volume of distribution and transcapillary passage of small unilamellar vesicles.

P. Beaumier, K. Hwang, K. F. Luk, 1982, Life sciences.

PRECLINICAL EVALUATION OF AN ANTI-TUMOR MONCLONAL ANTIBODY/ STREPTAVIDIN CONJUGATE FOR PRETARGETED 90Y RADIOIMMUNOTHERAPY IN A MOUSE XENOGRAFT MODEL

P. Beaumier, M. Hylarides, D. Axworthy, 1994 .

Cure of human carcinoma xenografts by a single dose of pretargeted yttrium-90 with negligible toxicity.

P. Beaumier, M. Hylarides, D. Axworthy, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Antitumor effects of L6, an IgG2a antibody that reacts with most human carcinomas.

K. Hellström, I. Hellström, P. Beaumier, 1986, Proceedings of the National Academy of Sciences of the United States of America.

Effect of liposome dose on the elimination of small unilamellar sphingomyelin/cholesterol vesicles from the circulation.

P. Beaumier, J. Slattery, K. Hwang, 1983, Research communications in chemical pathology and pharmacology.

An efficient method for loading indium-111 into liposomes using acetylacetone.

P. Beaumier, K. Hwang, 1982, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

186Re radioimmunotherapy of small cell lung carcinoma xenografts in nude mice.

L. Kunz, L. L. Kunz, J. Vanderheyden, 1991, Cancer research.

Simplified preformed chelate protein radiolabeling with technetium-99m mercaptoacetamidoadipoylglycylglycine (N3S-adipate).

J. Fitzner, P. Beaumier, T. Rao, 1998, Bioconjugate chemistry.

Antibody deposition in tumor in relation to blood clearance using a nephrectomized mouse model

J. Eary, W. Nelp, K. Krohn, 1985 .